Evidence map›Paper›PMID 36541772›Full record

ArticleAntimicrobial agents and chemotherapy2023

Multisite Detection of Tn

Shelby R Simar, Truc T Tran, Kirsten B Rydell, Diana Panesso, German A Contreras, Jose M Munita, Renzo O Cifuentes, Lilian M Abbo, Pranoti Sahasrabhojane, An Q Dinh and 5 more

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. The Impact ofPathogens (Basel, Switzerland) · 2024
    Review
  4. Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Shelby R SimarCenter for Infectious Diseases, University of Texas Health Science Center, School of Public Health, Houston, Texas, USA.
Truc T TranDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Kirsten B RydellDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Diana PanessoDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
German A ContrerasDivision of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Jose M MunitaGenomics and Resistant Microbes (GeRM) Group, Facultad de Medicina Clínica Alemana de Santiago, Universidad del Desarrollo, Santiago, Chile.
Renzo O CifuentesJackson Health System, Miami Transplant Institute, Miami, Florida, USA.
Lilian M AbboJackson Health System, Miami Transplant Institute, Miami, Florida, USA.
Pranoti SahasrabhojaneDepartment of Infectious Diseases, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
An Q DinhDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Dierdre B Axell-HouseDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Tor SavidgeTexas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas, USA.
Samuel A ShelburneDepartment of Infectious Diseases, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0001-9721-263X
Blake M HansonCenter for Infectious Diseases, University of Texas Health Science Center, School of Public Health, Houston, Texas, USA.ORCID 0000-0003-2949-7818
Cesar A AriasDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.ORCID 0000-0001-9054-9774
Houston Methodist · USThe University of Texas Health Science Center at Houston · USJackson Health System · USThe University of Texas MD Anderson Cancer Center · USTexas Children's Hospital · USUniversidad del Desarrollo · CL

Funding

Project 3: Functional Microbiome and Host Signatures in Transition from Commensal to pathogenP01AI152999 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HAAG, ANTHONY · 2020 to 2025
$12.0M
VENOUS: A translational study of enterococcal bacteremiaR01AI148342 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2020 to 2024
$3.9M
The LiaFSR system and antimicrobial peptide resistance in enterococciR01AI134637 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Cesar Augusto Arias · 2018 to 2026
$3.7M
Molecular Basis of Infectious Diseases Training GrantT32AI055449 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LORENZ, MICHAEL C · 2005 to 2025
$2.6M
POR Program on Genomic Prediction of Antimicrobial Resistance in VREK24AI121296 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2016 to 2025
$1.5M
Texas Medical Center Training Program in Antimicrobial ResistanceT32AI141349 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI GARSIN, DANIELLE A · 2019 to 2023
$1.3M
Enterococcus faecium virulence: A molecular and therapeutic approachR00AI072961 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2009 to 2010
$593k
Mobile Genetic Elements and Clinical Outcomes in Staphylococcus aureus BacteremiaK01AI148593 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HANSON, BLAKE M · 2020 to 2023
$519k
NIAID NIH HHS K01 AI148593NIAID NIH HHS K24 AI121296NIAID NIH HHS P01 AI152999NIAID NIH HHS R00 AI072961NIAID NIH HHS R01 AI134637NIAID NIH HHS R01 AI148342NIAID NIH HHS T32 AI055449NIAID NIH HHS T32 AI141349
6 · The paper itself

Abstract

In the United States,

Indexed as

Enterococcus faeciumGram-Positive Bacterial InfectionsVancomycin-Resistant EnterococciAnti-Bacterial AgentsBacterial ProteinsEnterococcus faecalisFloridaHumansTexasVancomycin ResistanceAnti-Bacterial AgentsBacterial Proteinsantimicrobial resistanceEnterococcusVRE

Identifiers

PMID36541772
PMCPMC9872605
OpenAlexW4312046058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.